“Adenocarcinoma”的搜索结果，显示 31-40 项，共有 8024 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

2. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Adenocarcinoma. Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to compare, in a non-inferiority fashion, the progression-free ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

5. 神经科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) treatment. Exclusion ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

10. 神经科- 临床试验- 妙佑医疗国际

    ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...